Correlation Between PAVmed Series and Neuropace

Can any of the company-specific risk be diversified away by investing in both PAVmed Series and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PAVmed Series and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PAVmed Series Z and Neuropace, you can compare the effects of market volatilities on PAVmed Series and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PAVmed Series with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of PAVmed Series and Neuropace.

Diversification Opportunities for PAVmed Series and Neuropace

-0.21

Correlation Coefficient

PAVmed Series  Neuropace

Very good diversification

The 3 months correlation between PAVmed and Neuropace is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding PAVmed Series Z and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and PAVmed Series is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PAVmed Series Z are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of PAVmed Series i.e., PAVmed Series and Neuropace go up and down completely randomly.

Pair Corralation between PAVmed Series and Neuropace

Assuming the 90 days horizon PAVmed Series Z is expected to generate 7.49 times more return on investment than Neuropace. However, PAVmed Series is 7.49 times more volatile than Neuropace. It trades about 0.16 of its potential returns per unit of risk. Neuropace is currently generating about 0.11 per unit of risk. If you would invest  0.93  in PAVmed Series Z on October 22, 2024 and sell it today you would earn a total of  0.30  from holding PAVmed Series Z or generate 32.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	94.74%
Values	Daily Returns

PAVmed Series Z  vs.  Neuropace

PAVmed Series Z

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in PAVmed Series Z are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile primary indicators, PAVmed Series showed solid returns over the last few months and may actually be approaching a breakup point.

Neuropace

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with PAVmed Series and Neuropace

The main advantage of trading using opposite PAVmed Series and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PAVmed Series position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind PAVmed Series Z and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.